NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

氣喘:開發中產品分析

Asthma (Respiratory) - Drugs In Development, 2021

出版商 Global Markets Direct 商品編碼 232777
出版日期 內容資訊 英文 931 Pages
訂單完成後即時交付
價格
氣喘:開發中產品分析 Asthma (Respiratory) - Drugs In Development, 2021
出版日期: 2021年08月30日內容資訊: 英文 931 Pages
簡介

氣喘是因氣管發炎而愈來愈狹窄的慢性疾病。氣喘的症狀有呼吸急促、胸悶及疼痛、慢性咳嗽等。其原因有容易氣喘的家族病史、體重過重、抽煙、曝露在廢氣及其他大氣污染物質中等等。氣喘代表性治療藥有吸入式皮質類固醇藥,白三烯拮抗劑,抗組織胺藥物,充血消除劑等。

本報告提供氣喘治療藥的開發中產品概要和臨床實驗的各階段產品概要,提供您主要企業簡介,藥物簡介,開發中產品的最新趨勢等資訊。

簡介

氣喘概要

治療藥的開發

治療藥的評估

開發治療藥的企業

藥物簡介

暫停中的計劃

開發中止的產品

產品開發的里程碑

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC13058IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Drugs In Development, 2021, provides an overview of the Asthma (Respiratory) pipeline landscape.Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Asthma - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Asthma (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 1, 16, 40, 48, 10, 136, 38 and 9 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 33 and 10 molecules, respectively.

Asthma (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Asthma (Respiratory).
  • The pipeline guide reviews pipeline therapeutics for Asthma (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Asthma (Respiratory) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Asthma (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Asthma (Respiratory)

Reasons to Buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Asthma (Respiratory).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Asthma (Respiratory) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

  • Introduction
  • Asthma - Overview
  • Asthma - Therapeutics Development
  • Asthma - Therapeutics Assessment
  • Asthma - Companies Involved in Therapeutics Development
  • Asthma - Drug Profiles
  • Asthma - Dormant Projects
  • Asthma - Discontinued Products
  • Asthma - Product Development Milestonesh
  • Appendix

List of Tables

List of Tables

  • Number of Products under Development for Asthma, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Asthma - Pipeline by 2A Pharma AB, 2021
  • Asthma - Pipeline by 3SBio Inc, 2021
  • Asthma - Pipeline by 4D Pharma Plc, 2021
  • Asthma - Pipeline by AazeinTx Inc, 2021
  • Asthma - Pipeline by AB Science SA, 2021
  • Asthma - Pipeline by AbbVie Inc, 2021
  • Asthma - Pipeline by Abeome Corp, 2021
  • Asthma - Pipeline by Actinobac Biomed Inc, 2021
  • Asthma - Pipeline by Adare Pharma Solutions, 2021
  • Asthma - Pipeline by Advagene Biopharma Co Ltd, 2021
  • Asthma - Pipeline by Aeon Respire Inc, 2021
  • Asthma - Pipeline by Airbase Breathing Co LLC, 2021
  • Asthma - Pipeline by Akeso Inc, 2021
  • Asthma - Pipeline by Aldeyra Therapeutics Inc, 2021
  • Asthma - Pipeline by Algomedix Inc, 2021
  • Asthma - Pipeline by ALK-Abello AS, 2021
  • Asthma - Pipeline by AllerGen NCE Inc, 2021
  • Asthma - Pipeline by Allergy Therapeutics Plc, 2021
  • Asthma - Pipeline by Amgen Inc, 2021
  • Asthma - Pipeline by Amphastar Pharmaceuticals Inc, 2021
  • Asthma - Pipeline by AnGes Inc, 2021
  • Asthma - Pipeline by Antisense Therapeutics Ltd, 2021
  • Asthma - Pipeline by Apollo Therapeutics LLC, 2021
  • Asthma - Pipeline by Aquilon Pharmaceuticals SA, 2021
  • Asthma - Pipeline by Argenx SE, 2021
  • Asthma - Pipeline by Artax Biopharma Inc, 2021
  • Asthma - Pipeline by Artizan Biosciences Inc, 2021
  • Asthma - Pipeline by ASIT Biotech SA, 2021
  • Asthma - Pipeline by Aslan Pharmaceuticals Ltd, 2021
  • Asthma - Pipeline by AstraZeneca Plc, 2021
  • Asthma - Pipeline by Athos Therapeutics Inc, 2021
  • Asthma - Pipeline by Atrapos Therapeutics LLC, 2021
  • Asthma - Pipeline by AusBio Ltd, 2021
  • Asthma - Pipeline by Avidin Biotechnology Ltd, 2021
  • Asthma - Pipeline by Bai Shuo Beijing Pharmaceutical Technology Co Ltd, 2021
  • Asthma - Pipeline by Bilix Co Ltd, 2021
  • Asthma - Pipeline by BioArdis LLC, 2021
  • Asthma - Pipeline by Biocon Ltd, 2021
  • Asthma - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, 2021
  • Asthma - Pipeline by BiOraliX BV, 2021
  • Asthma - Pipeline by BiosanaPharma BV, 2021
  • Asthma - Pipeline by Biosion Inc, 2021
  • Asthma - Pipeline by Biotoxtech Co Ltd, 2021
  • Asthma - Pipeline by Boehringer Ingelheim International GmbH, 2021
  • Asthma - Pipeline by Celltrion Inc, 2021
  • Asthma - Pipeline by Celon Pharma SA, 2021
  • Asthma - Pipeline by Centrymed Pharmaceutical Inc, 2021
  • Asthma - Pipeline by Chia Tai Tianqing Pharmaceutical Group Co Ltd, 2021
  • Asthma - Pipeline by Chiesi Farmaceutici SpA, 2021
  • Asthma - Pipeline by Chronic Airway Therapeutics Ltd, 2021
  • Asthma - Pipeline by Crossject SA, 2021
  • Asthma - Pipeline by CrystalGenomics Inc, 2021
  • Asthma - Pipeline by CSL Ltd, 2021
  • Asthma - Pipeline by CSPC Pharmaceutical Group Ltd, 2021
  • Asthma - Pipeline by Cumberland Pharmaceuticals Inc, 2021
  • Asthma - Pipeline by Curovir AB, 2021
  • Asthma - Pipeline by Cynata Therapeutics Ltd, 2021
  • Asthma - Pipeline by Cytokinetics Inc, 2021
  • Asthma - Pipeline by Daewoong Pharmaceutical Co Ltd, 2021
  • Asthma - Pipeline by Daiichi Sankyo Co Ltd, 2021
  • Asthma - Pipeline by Defensin Therapeutics ApS, 2021
  • Asthma - Pipeline by Dnarx LLC, 2021
  • Asthma - Pipeline by EffectorBio Inc, 2021
  • Asthma - Pipeline by EmphyCorp Inc, 2021
  • Asthma - Pipeline by Energenesis Biomedical Co Ltd, 2021
  • Asthma - Pipeline by Enzychem Lifesciences Corp, 2021
  • Asthma - Pipeline by Epsilon Molecular Engineering Inc, 2021
  • Asthma - Pipeline by ethris GmbH, 2021
  • Asthma - Pipeline by EURRUS Biotech GmbH, 2021
  • Asthma - Pipeline by Evelo Biosciences Inc, 2021
  • Asthma - Pipeline by Evergreen Therapeutics Inc, 2021
  • Asthma - Pipeline by Exotect LLC, 2021
  • Asthma - Pipeline by Fibrotherapeutics Inc, 2021
  • Asthma - Pipeline by Foresee Pharmaceuticals Co Ltd, 2021
  • Asthma - Pipeline by Galapagos NV, 2021
  • Asthma - Pipeline by Genentech USA Inc, 2021
  • Asthma - Pipeline by Generium, 2021
  • Asthma - Pipeline by GeneScience Pharmaceuticals Co Ltd, 2021
  • Asthma - Pipeline by Genrix (Shanghai) Biopharmaceutical Co Ltd, 2021
  • Asthma - Pipeline by GI Innovation Co Ltd, 2021
  • Asthma - Pipeline by GlaxoSmithKline Plc, 2021
  • Asthma - Pipeline by Glenmark Pharmaceuticals Ltd, 2021
  • Asthma - Pipeline by GliaCure Inc, 2021
  • Asthma - Pipeline by GlycoMira Therapeutics Inc, 2021
  • Asthma - Pipeline by Gossamer Bio Inc, 2021
  • Asthma - Pipeline by Gurus BioPharm, 2021
  • Asthma - Pipeline by Harbour BioMed (Guangzhou) Co Ltd, 2021
  • Asthma - Pipeline by HEC Pharma Co Ltd, 2021
  • Asthma - Pipeline by Re-Pharm Ltd, 2021
  • Asthma - Pipeline by Regeneron Pharmaceuticals Inc, 2021
  • Asthma - Pipeline by Respiratorius AB, 2021
  • Asthma - Pipeline by Revalesio Corp, 2021
  • Asthma - Pipeline by Revolo Biotherapeutics Ltd, 2021
  • Asthma - Pipeline by Ribomic Inc, 2021
  • Asthma - Pipeline by S-TARget therapeutics GmbH, 2021
  • Asthma - Pipeline by Sama Pharm Co Ltd, 2021
  • Asthma - Pipeline by Sanofi, 2021
  • Asthma - Pipeline by Santhera Pharmaceuticals Holding AG, 2021
  • Asthma - Pipeline by Seelos Therapeutics, Inc., 2021
  • Asthma - Pipeline by Shandong Boan Biotechnology Co Ltd, 2021
  • Asthma - Pipeline by Shanghai KE Pharmaceutical Co Ltd, 2021
  • Asthma - Pipeline by Shanghai Kexin Biotech Co Ltd, 2021
  • Asthma - Pipeline by Shanghai Maiji Biotechnology Co Ltd, 2021
  • Asthma - Pipeline by Shanghai Novamab Biopharmaceuticals Co Ltd, 2021
  • Asthma - Pipeline by Shenzhen Forward Pharmaceutical Co Ltd, 2021
  • Asthma - Pipeline by Shouyao Holding Co Ltd, 2021
  • Asthma - Pipeline by Sichuan Yuanda Shuyang Pharmaceutical Co Ltd, 2021
  • Asthma - Pipeline by Siolta Therapeutics Inc, 2021
  • Asthma - Pipeline by SolAeroMed Inc, 2021
  • Asthma - Pipeline by sterna biologicals Gmbh & Co KG, 2021
  • Asthma - Pipeline by Suzhou Connect Biopharmaceuticals Ltd, 2021
  • Asthma - Pipeline by Synermore Biologics Co Ltd, 2021
  • Asthma - Pipeline by Taiho Pharmaceutical Co Ltd, 2021
  • Asthma - Pipeline by TaiwanJ Pharmaceuticals Co Ltd, 2021
  • Asthma - Pipeline by TAK-Circulator Corp, 2021
  • Asthma - Pipeline by Tarus Therapeutics Inc, 2021
  • Asthma - Pipeline by TCF GmbH, 2021
  • Asthma - Pipeline by Tetherex Pharmaceuticals Corp, 2021
  • Asthma - Pipeline by Tetragenetics Inc, 2021
  • Asthma - Pipeline by Teva Pharmaceutical Industries Ltd, 2021
  • Asthma - Pipeline by TFF Pharmaceuticals Inc, 2021
  • Asthma - Pipeline by The Geneva Biotech Center SA, 2021
  • Asthma - Pipeline by The United Laboratories International Holdings Ltd, 2021
  • Asthma - Pipeline by Torrent Pharmaceuticals Ltd, 2021
  • Asthma - Pipeline by Translational Biosciences, 2021
  • Asthma - Pipeline by Trio Medicines Ltd, 2021
  • Asthma - Pipeline by Tunitas Therapeutics Inc, 2021
  • Asthma - Pipeline by United Biomedical Inc, 2021
  • Asthma - Pipeline by Vactech Oy, 2021
  • Asthma - Pipeline by Vanworld Pharmaceutical (Rugao) Company Ltd, 2021
  • Asthma - Pipeline by Vascular BioSciences, 2021
  • Asthma - Pipeline by Vasomune Inc, 2021
  • Asthma - Pipeline by Vectura Group Plc, 2021
  • Asthma - Pipeline by Verona Pharma Plc, 2021
  • Asthma - Pipeline by VGSK Technologies Inc, 2021
  • Asthma - Pipeline by Vicenna Pharmaceuticals Inc, 2021
  • Asthma - Pipeline by Virtici LLC, 2021
  • Asthma - Pipeline by Yuhan Corp, 2021
  • Asthma - Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, 2021
  • Asthma - Pipeline by Zhengda Tianqing Pharmaceutical Group Co Ltd, 2021
  • Asthma - Pipeline by Zhuhai Trinomab Biotechnology Co Ltd, 2021
  • Asthma - Dormant Projects, 2021
  • Asthma - Discontinued Products, 2021

List of Figures

List of Figures

  • Number of Products under Development for Asthma, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021